Literature DB >> 16759716

Detection of myocardial involvement of rheumatic heart disease with contrast-enhanced magnetic resonance imaging.

Eui-Young Choi, Se-Jung Yoon, Sang-Hyun Lim, Byoung-Wook Choi, Jong-Won Ha, Dong-Hwan Shin, Namsik Chung.   

Abstract

While valvular involvement of rheumatic heart disease can be easily detected with conventional echocardiography by evaluating morphologic change of the valve, it still remains problematic to determine whether there is myocardial fibrosis after rheumatic fever and if yes, how much extent it involves. This case demonstrated that contrast-enhanced magnetic resonance imaging could exactly detect and define the extent of myocardial fibrosis in a patient with rheumatic valvular heart disease by comparing surgically obtained tissue analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759716     DOI: 10.1016/j.ijcard.2006.04.013

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Delayed gadolinium enhancement in the atrial wall: a novel finding in 3 patients with rheumatic heart disease.

Authors:  Jabi Shriki; Brenna Talkin; Isac C Thomas; Ali Farvid; Patrick M Colletti
Journal:  Tex Heart Inst J       Date:  2011

2.  Prognostic Value of Late Gadolinium Enhancement in Postoperative Morbidity following Mitral Valve Surgery in Rheumatic Mitral Stenosis.

Authors:  Teuku Muhammad Haykal Putra; Renan Sukmawan; Elen Elen; Celly A Atmadikoesoemah; Dwita Rian Desandri; Manoefris Kasim
Journal:  Int J Angiol       Date:  2019-08-06

Review 3.  Tailoring the Ablative Strategy for Atrial Fibrillation: A State-of-the-Art Review.

Authors:  Zefferino Palamà; Martina Nesti; Antonio Gianluca Robles; Antonio Scarà; Silvio Romano; Elena Cavarretta; Maria Penco; Pietro Delise; Mariano Rillo; Leonardo Calò; Luigi Sciarra
Journal:  Cardiol Res Pract       Date:  2022-02-28       Impact factor: 1.990

Review 4.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

5.  Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation.

Authors:  Ruchika Meel; Richard Nethononda; Elena Libhaber; Therese Dix-Peek; Ferande Peters; Mohammed Essop
Journal:  Cardiovasc J Afr       Date:  2018-02-06       Impact factor: 1.167

6.  Left Ventricular Dimension after Mitral Valve Surgery in Rheumatic Mitral Stenosis: The Impact of Myocardial Fibrosis.

Authors:  Teuku Muhammad Haykal Putra; Renan Sukmawan; Dwita Rian Desandri; Celly A Atmadikoesoemah; Elen Elen; Manoefris Kasim
Journal:  J Tehran Heart Cent       Date:  2020-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.